Please select the country or location you would like to see content from.
country picker icon
Health Secrets
article icon


Orajel Pain Relief

Mohommed Essop-Adam
Reviewed by Mohommed Essop-AdamReviewed on 30.10.2023 | 2 minutes read

Orajel is for temporary rapid relief of toothache pain in the mouth.

Orajel is a local anaesthetic with two strengths: single-strength over the counter and double-strength behind the counter. It comes only in a gel formulation, which is excellent for targeting a specific area.

Who is it for

This local anaesthetic provides effective pain relief from toothache, ulcers and denture irritation. Orajel contains a double-strength local anaesthetic formulation (benzocaine 20%), making it suitable for all altitudes of pain. The formulation is a gel, which makes it easier to target a specific area. Also, evidence suggests that benzocaine as a local anaesthetic is more therapeutic for pain relief in the mouth than lidocaine, the ingredient in Anbesol. This can be used from 12 years onwards and is also sugar-free, making it suitable for people with diabetes.

How does it work?

Orajel has one key ingredient, which is benzocaine. This local anaesthetic works by temporarily blocking pain signals, causing numbness, and relieving pain in the area it is applied to.

Should anybody not take it

This gel is not suitable for children under the age of 12. It is also not suitable for anyone allergic to the following ingredients in the Orajel. It is unsafe in patients who suffer from poor haemoglobin production. If you are pregnant or breastfeeding, it is important you speak to your doctor before using Orajel.

Are there any side effects?

If you have a mouth ulcer and has gotten bigger or is not improving while using Anbesol, you should stop using it and ask your pharmacist or doctor for advice. Any side effect will most likely be a result of an allergic reaction. If you notice a side effect, contact your doctor or pharmacist.

Was this helpful?

Was this helpful?

Mohommed Essop-Adam
Reviewed by Mohommed Essop-Adam
Reviewed on 30.10.2023